Quantcast
Last updated on April 16, 2014 at 12:43 EDT

Latest Pharmaceutical sciences Stories

2014-03-27 08:35:30

NEWARK, N.J., March 27, 2014 /PRNewswire-USNewswire/ -- MBA student Rema Bitar spent nearly five years working as a drug discovery scientist at Merck before she decided to enter the Pharmaceutical Management Program at Rutgers Business School. That work experience was also one of the things that helped her land a Pharmaceutical Industry Scholarship, a coveted award that provides selected students in the Pharmaceutical Management Program with full tuition to pay for their studies....

2014-03-27 08:34:36

AVP-825 relies on novel closed palate Breath Powered(TM) drug delivery technology YARDLEY, Pa., March 27, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for AVP-825, an innovative closed-palate Breath Powered(TM) investigational drug-device combination product for the acute treatment of migraine. As previously reported, the 505(b)(2) NDA for AVP-825 includes clinical data developed by OptiNose including a pivotal phase...

2014-03-27 08:34:12

Cannabinoid Receptor 1 is most recent GPCR to be targeted by RuiYi's iCAPS platform LA JOLLA, Calif. and SHANGHAI, March 27, 2014 /PRNewswire/ -- RuiYi, Inc. announced today a $15 million Series B financing by existing investors: 5AM Ventures, Versant Ventures, Apposite Capital, SR One, the independent corporate healthcare venture capital fund of GlaxoSmithKline, Merck Serono Ventures, the strategic corporate venture fund of Merck Serono, and Aravis SA. RuiYi has a pipeline of...

2014-03-27 08:33:44

Jury awards Mylan $106.7 million in damages PITTSBURGH, March 27, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that, after a trial in the United States District Court for the District of New Jersey, a jury returned a verdict in favor of Mylan in its breach of contract lawsuit against GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride Extended-release (ER) Tablets. The jury decided that GSK owes Mylan $106.7 million in damages. Mylan's claims were based...

2014-03-27 08:33:35

ATLANTA, March 27, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has resubmitted its New Drug Application for ILUVIEN(®) to the U.S. Food and Drug Administration (FDA). At this time, Alimera awaits the FDA's acceptance of the resubmission and a Prescription Drug User Fee Act (PDUFA) date. Alimera...

2014-03-27 08:33:09

MUMBAI, India, March 27, 2014 /PRNewswire/ -- Piramal Enterprises Limited (PEL) ("PEL", NSE: PEL, BSE: 500302) announces that its Good Laboratory Practices (GLP) Department at Research & Development (R&D) facility in Goregaon, Mumbai has received the GLP Compliance Certification from the National Good Laboratory Practice Compliance Monitoring Authority (NGCMA), Government of India. (Logo: http://photos.prnewswire.com/prnh/20130724/629310 )...

2014-03-27 08:29:37

NEW YORK, March 27, 2014 /PRNewswire/ -- Across the globe, there are over 13 million new cancer cases each year. By 2030, it is estimated by the International Agency for Research on Cancer (IARC) that there will be approximately 21.4 million new cancer cases and 13.2 million cancer deaths worldwide. Some of the more common (and deadly) forms of cancer are head and neck cancer, which account for approximately 600,000 new cases worldwide each year and result in a five-year survival rate...

2014-03-27 08:26:39

ALBANY, New York, March 27, 2014 /PRNewswire/ -- MarketResearchReports.Biz includes new market research report "Plant Growth Regulators Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018" to its large collection of research report. Plant growth regulators, also known as plant hormones are chemicals occurring in low concentrations, which promote plant growth by increasing the supply or availability of primary nutrients to the plant....

2014-03-26 23:33:00

The Corporate Whistleblower Center is strongly encouraging pharmaceutical industry insiders, or physicians to call them at 866-714-6466 if they possess substantial proof a drug company is knowingly off-labeling their pharmaceutical product as a way to increase profits, as pointed out in a recent Justice Department press release. The Whistleblower Center believes off-labeling puts patients at risk, and well documented proof of this type of activity can produce substantial whistleblower...

2014-03-26 23:01:45

Legislation being considered today by Florida lawmakers could increase prescription drug costs by more than $12 billion over the next 10 years. Washington, D.C. (PRWEB) March 26, 2014 Legislation (HB 1001, HB 745, SB 1014 and SB 1354) being considered today by Florida lawmakers could increase prescription drug costs by more than $12 billion over the next 10 years for the state’s employers, seniors, unions, and consumers, the Pharmaceutical Care Management Association (PCMA) said today....


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »